Publication date: November 2026 Source: The Lancet Diabetes & Endocrinology, Volume 14, Issue 11 Author(s): Kamlesh Khunti, Mark P Funnell, Patrick J Highton, Ashkon Ardavani, Javed Butler, Jon Campbell, Melanie J Davies, Rachel Evley, Jose C Florez, Jason Gaglia, Rohit N Kulkarni, Nicolas Musi, Leigh Perreault, Bryce B Reeve, Sylvia E Rosas, Ash Routen, Zobair Younossi, Nuha El Sayed
Disease modification outcomes in type 2 diabetes: a modified Delphi. // The Lancet Diabetes & Endocrinology. – URL: https://www.sciencedirect.com/science/article/pii/S2213858726002433?dgcid=rss_sd_all
Disease modification outcomes in type 2 diabetes: a modified Delphi. The Lancet Diabetes & Endocrinology. https://www.sciencedirect.com/science/article/pii/S2213858726002433?dgcid=rss_sd_all
“Disease modification outcomes in type 2 diabetes: a modified Delphi.” The Lancet Diabetes & Endocrinology.
@article{article68359,
title = {Disease modification outcomes in type 2 diabetes: a modified Delphi},
journal = {The Lancet Diabetes \& Endocrinology},
url = {https://www.sciencedirect.com/science/article/pii/S2213858726002433?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...